MedCity News October 1, 2021
The company recently published new results on its MOBILE study, which found that CGM use increased time in range for people with Type 2 diabetes. New data shows people who stopped using a CGM saw time in range decrease.
As Dexcom works to build a case for broader use of continuous glucose monitors, the company touted new data that point to CGM use for people with Type 2 diabetes.
New results from a study funded by Dexcom found that adults with Type 2 diabetes saw a significant improvement in time-in-range when they used a CGM, but those who stopped using it for six months saw their time-in-range decrease.
Earlier this year, Dexcom shared initial findings from the MOBILE study,...
Today's Sponsors
Today's Sponsor